UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 9 | September 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 4
April-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2504D09


Registration ID:
560920

Page Number

n72-n79

Share This Article


Jetir RMS

Title

Validated Stability-Indicating RP-HPLC Method for the Simultaneous Quantification of Antiretroviral Agents in Bulk and Pharmaceutical Dosage Forms

Abstract

A simple, rapid, precise, and accurate reverse-phase high-performance liquid chromatography (RP-HPLC) method was developed and validated for the simultaneous estimation of Dolutegravir and Rilpivirine in bulk and pharmaceutical dosage forms. Chromatographic separation was achieved using an INERTSIL ODS column (200 mm × 4.6 mm, 5 μm particle size) with a mobile phase consisting of methanol and phosphate buffer (pH 3.5) in the ratio of 60:40 v/v, delivered at a flow rate of 1.5 mL/min. Detection was carried out at 230 nm using a UV detector. The retention times for Dolutegravir and Rilpivirine were found to be 3.4 minutes and 4.3 minutes, respectively. The method demonstrated excellent linearity over the concentration ranges of 50–250 µg/mL for Dolutegravir and 25–125 µg/mL for Rilpivirine, with correlation coefficients (r²) of 0.999 for both drugs. System suitability parameters such as theoretical plates and tailing factor were within acceptable limits. The %RSD values for precision and intermediate precision were below 2%, indicating high repeatability and reproducibility. The LOD and LOQ were found to be 3.08 µg/mL and 10.10 µg/mL for Dolutegravir and 3.0 µg/mL and 10.02 µg/mL for Rilpivirine, respectively. Forced degradation studies confirmed the method’s stability-indicating capability under acidic, basic, oxidative, thermal, and photolytic conditions. This validated RP-HPLC method is suitable for the routine quality control and stability analysis of Dolutegravir and Rilpivirine in bulk drug and pharmaceutical formulations.

Key Words

Dolutegravir, Rilpivirine, Methanol, Phosphate Buffer, Method Validation.

Cite This Article

"Validated Stability-Indicating RP-HPLC Method for the Simultaneous Quantification of Antiretroviral Agents in Bulk and Pharmaceutical Dosage Forms", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 4, page no.n72-n79, April-2025, Available :http://www.jetir.org/papers/JETIR2504D09.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Validated Stability-Indicating RP-HPLC Method for the Simultaneous Quantification of Antiretroviral Agents in Bulk and Pharmaceutical Dosage Forms", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 4, page no. ppn72-n79, April-2025, Available at : http://www.jetir.org/papers/JETIR2504D09.pdf

Publication Details

Published Paper ID: JETIR2504D09
Registration ID: 560920
Published In: Volume 12 | Issue 4 | Year April-2025
DOI (Digital Object Identifier):
Page No: n72-n79
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000123

Print This Page

Current Call For Paper

Jetir RMS